As the 340B drug discount program has ballooned in size over the last several years, some hospitals are getting creative about how to make the program work for their own financial gain.
Stephanie Silverman
Advertisement
Articles by Stephanie Silverman
Advertisement
Latest Updated Articles
Acquisitions by 340B Hospitals Drive Up Healthcare CostsJuly 10th 2015
Advertisement
Advertisement
Trending on OncLive
1
Belzutifan Plus Lenvatinib Raises New Sequencing Questions in Advanced RCC
2
EU, Japanese Approval Is Sought for Savolitinib Plus Osimertinib in MET-Driven EGFR-Mutated NSCLC
3
Dr Hansen on the Potential Role of GPRC5D-Targeted CAR T-Cell Therapy in Myeloma
4
Camizestrant Approval Paves the Way for ctDNA-Guided Switching in Emergent ESR1-Mutated HR+/HER2– Advanced Breast Cancer
5